Cancer is caused by the accumulation of a critical number of somatic mutations (drivers) that offer fitness advantage to tumor cells. Moderately deleterious passengers, suppressing cancer progression, and mini-drivers, mildly beneficial to tumors, can profoundly alter the cancer evolutionary landscape. This observation prompted Cancer is an evolutionary disease caused by genomic instability resulting from sequential somatic mutations accumulated over the lifetime of an individual 1-3 . These mutations arise due to both exogenous (for example, DNA damage due to UV radiation and harmful environmental factors) and endogenous factors (such as errors during mitosis or epigenetic alterations). It is believed that virtually all manifestations of cancer are due to accumulation of such mutations in oncogenes and tumor suppressor genes 4 . The development of nextgeneration sequencing technologies has made whole-genome sequencing possible 5 . These tour de force studies have revealed the occurrence of hundreds or even tens of thousands of genetic mutations in a variety of cancers 6-10
us to develop a stochastic evolutionary model intended to probe the interplay of drivers, mini-drivers and deleterious passengers in tumor growth over a broad range of fitness values and mutation rates. Below a (small) threshold number of drivers tumor growth exhibits a plateau (dormancy) with large burst occurring when a driver achieves fixation, reminiscent of intermittency in dissipative dynamical systems. The predictions of the model, in particular the relationship between the average number of passenger mutations versus drivers in a tumor, is in accord with clinical data on several cancers. When deleterious drivers are included, we predict a non-monotonic growth of tumors as the mutation rate is varied with shrinkage and even reversal occurring at very large mutation rates. This surprising finding explains the paradoxical observation that high chromosomal instability (CIN) correlates with improved prognosis in a number of cancers compared with intermediate CIN.
and hence influence the growth dynamics of cell populations 18,21 . In the same spirit, it has been proposed that mildly beneficial passengers (or "mini-drivers") could also offer fitness advantages to tumors 22, 23 . It is likely that the cell population would go extinct as weakly selected, moderately deleterious mutations accumulate continuously, which is the Muller's ratchet effect 24, 25 . The presence of mildly beneficial mutations can counteract this effect because even a small fraction of mini-drivers is sufficient to maintain cellular homeostasis 26 .
Recently Castro-Giner et.al. 23 have emphasized the important role mini-drivers might play in promoting tumor growth. Here, we quantitatively investigate the consequence of the interplay between driver, mini-driver, and deleterious passenger in the dynamics of tumor progression. Using an extension of the recently proposed model 18,19 , we analyze systematically distinct somatic mutations and their interactions in order to elucidate the mechanism of cancer progression. Our theoretical study, which belongs to a class of mathematical description of tumor growth based on evolutionary dynamics 27 , leads to the following predictions:
(i) Mini-drivers, even if present in small numbers, can offset the effects of deleterious passengers and maintain population homeostasis as long as the number of drivers is small. (ii) If the number of drivers remains below a threshold value, the neutralizing effect of mini-drivers and deleterious passengers drive the tumor to dormancy for a period of time. (iii) Using distinct choices for the dependence of the cell death rate on the size of the population, we find that the number of drivers leading to unbounded growth is ∼ 4, which is similar to a recent estimate 28 . (iv) The predicted relationship between the total number of passengers as a function of driver mutations is in very good agreement with clinical data on several cancers. Interestingly, this relationship varies greatly from one trajectory to another, providing insights into the origins of cancer heterogeneity. (v) Our work also shows that inclusion of deleterious drivers results in reversal of tumor growth at high mutation rates (> 10 −5 ), which tidily explains the seemingly paradoxical correlation between high chromosomal instability and improved prognosis in a variety of cancers.
RESULTS
In principle, five distinct genetic mutations could appear in daughter cells when cells divide. Drivers and passengers are mutations which exert strong and weak influences on cell proliferation, respectively. These mutations could be beneficial or deleterious, which separately promote or decrease cell reproduction. The four types of somatic mutations are beneficial drivers (Ds), deleterious drivers (DDs), beneficial passengers (or mini-drivers (MDs)), and deleterious passengers (DPs). The fifth is a neutral genetic alteration with negligible effect on cancer progression.
Although all five types of mutations could occur in somatic cells, their influences on cancer development vary greatly. Neutral passengers can be neglected because they have no influence on cell proliferation or cell death. The deleterious driver (DDs) either slows down the proliferation of cells or increases their death rate strongly, leading eventually to rapid extinction of cells. We first disregard DDs because they are unlikely to get fixation in the population but will discuss their potential role at the end of this article.
Because a large number of passengers have been discovered in cancer cells that accompany driver mutations, they are likely to play an important role during cancer progression even though their effects have not been systematically studied. Simulations based on the tug-ofwar model 18, 19 show that DPs and Ds work against each other during cancer progression. The results suggest that passengers could even overwhelm the effects of drivers provided the initial tumor size is not too large, resulting in reversal or even elimination of tumor progression.
This finding contradicts the standard lore, which assume that the influence of passengers could be totally ignored 29 . The relevance of MDs has been discussed in the context of asexual populations where it is found that such mutations are important in maintaining population homeostasis 26 . In the absence of such mutations cell population would go extinct rapidly because of the Muller's ratchet effect 24,25 . However, the relevance of mini-drivers, whose importance has been emphasized only recently 23 , has not been quantitatively assessed in previous evolutionary models dealing with cancer progression.
We first consider the interplay of DPs, MDs, and Ds in controlling cancer progression, with primary focus being the effect of MDs on tumor growth. A single driver mutation confers a fitness advantage s d . Similarly, a cell acquires a fitness advantage s md or disadvantage s dp as a single mini-driver or deleterious passenger accumulates, respectively. The fitness values satisfy the inequality s d s md , s dp because the impact of driver mutations is much stronger than the mini-drivers and passengers. For simplicity, we choose s md = s dp ≡ s p for the fitness of MDs and DPs in most of the simulations. The consequences of relaxing this assumption is discussed in the Supplementary Information (SI). It may appear that the inclusion of mini-drivers should merely renormalize the fitness advantage of the drivers.
However, because the frequency of accumulation of Ds and MDs and their numbers are vastly different, this is not the case as we establish here.
Tumor progression is based on evolutionary dynamics described in Fig. 1 . A cell divides at a rate B(d, md, dp) where d, md and dp are the number of Ds, MDs and DPs, respectively.
The only requirement is that B(d, md, dp) should be an increasing function of d and md, and should decrease as dp increases. The following form B(d, md, dp), a generalization of the one used previously 18 ,
satisfies the criterion stated above. It is likely that the chosen functional form for B(d, md, dp)
may not affect the overall growth kinetics but the details might differ depending on the precise form of B(d, md, dp). For comparison with previous work 18 , we assume that the death rate D(N ) is given by,
where N 0 is the initial size of the population without mutations. Other forms of D(N ) are also considered below. Cells acquire genetic mutations at a rate µ per locus after division.
The numbers of driver, beneficial, and deleterious passenger loci are L d , L md , L dp , which satisfy L d (L md + L dp ) ≡ L p . Thus, the frequency of driver and passenger mutations per cell division are given by µL d , µL md , and µL dp as illustrated in Fig. 1 , which also shows the kinetic scheme for cancer progression. Unless otherwise stated we use the numerical parameters in Table 1 .
The stochastic growth for cancer progression is implemented using the Gillespie algorithm 30 with defined reaction rates given in Fig. 1 Interplay of deleterious passengers and mini-drivers lead to population homeostasis. In contrast to the results in Fig. S1 , the population dynamics changes dramatically when the effect of MDs are also taken into account. In a different context, it has been shown that beneficial passengers are required for the maintenance of a stable asexual population over a prolonged period of time 26 . Mini-drivers, which confer fitness advantage to cancer cells also accumulate during the progression of cancers as a result of stochastic genetic mutations 22,23 . The total number of loci (L p ) for passenger mutations is fixed. A small fraction of such mutations is MDs. The number of MDs changes with time and can only be determined from the trajectories generated using the evolutionary dynamics described in Fig. 1 . A generic evolutionary model 31 probing the fate of finite population shows that the frequency of acquiring beneficial mutations is not a constant, but decreases as the fitness of cells increases. A corollary of this observation is that deleterious mutations accumulate more readily as the fitness of cells increases. From Eq. (1), we note that the fitness of cells is determined by the difference md − dp in the absence of drivers. We assume a linear relation for the fraction F M D , which is proportional to the probability of acquiring a MD upon cell division, yielding,
Note that F M D decreases as cell fitness increases. In the presence of both DPs and MDs,
The population is not driven to extinction but reaches homeostasis; N (t) fluctuates around a constant value for long periods of time ( Fig. 2A ).
In order to assess the robustness of the finding that interplay of DPs and MDs confers homeostasis ( Fig. 2A ), we also performed simulations using another form of F M D (see SI for details). An example displayed in the inset to Fig. S2 shows that a small fraction of MDs is sufficient to maintain homeostasis over a wide parameter range. The results in Fig. 2A and the inset of Fig. S2 show that homeostasis can be maintained although passenger mutations accumulate continually. This is accomplished through regulation of the ratio of MDs to DPs. However, it is believed that during cancer progression, homeostasis is intermittently halted leading to the population growth and eventual occurrence of the disease due to the accumulation of driver mutations.
Drivers qualitatively alter growth of tumors. The case without MDs has been investigated previously 18 using a model in which cells accumulate only DPs and driver mutations. The growth trajectories are quite different even under the same initial conditions ( Fig. 2B ), due to the stochastic occurrence of driver mutations. Once a driver mutation sweeps through the whole population, N (t), increases rapidly. However, the system size shrinks gradually before the appearance of an additional driver mutation, which is seen in N (t) curves as an inverse sawtooth pattern ( Fig. 2D ). Thus, there is a tug-of-war between the beneficial driver mutations and DPs, with the former overwhelming the latter if there is sufficient number of drivers. Interestingly, there is a critical population size, N * , in this model with the unbounded growth occurring above N * and extinction of N (t) below it ( Fig. 2B ). If the fixation frequency of driver mutations becomes very low, the whole population would be eliminated because of the accumulation of DPs. This occurs in the long time limit only for small values of N 0 , prompting a suggestion that a plausible route to therapy is to enhance the rate of DPs production. On the other hand, drivers would win and lead to the occurrence of cancer as they get fixation frequently when N 0 exceeds N * .
Intermittency in cancer growth is driven by mini-drivers. Although the tug-ofwar model revealed the importance of DPs, the very existence of N * have not been documented in tumor evolution. In addition, N (t) does not go extinct if driver mutations appear rarely or not at all, indicating that both the driver mutations and MDs are crucial for explaining the dynamics of cancer progression. In our model that also includes MDs, we observe a totally different growth dynamics (Fig. 2C ). For most of the time, homeostasis is maintained with very small variations in N (t) until the appearance of a single driver mutation. Once the driver mutation sweeps the whole population, N (t) increases rapidly (see Tumor growth rate increases with mutation rate. Typically, cancers appear more rapidly upon exposure to chemical carcinogens or when the mutation rate µ is increased either by environmental fluctuations or genetic mutations at late stages 3 . Interestingly, in the tug-of-war model 18 , it is found that the probability of cancer is low if µ exceeds a critical value, µ c . At the smallest µ ( = 10 −9 ) the increase in N (t) is slow (orange in Fig. 3A) whereas at µ = 10 −8 the growth is more rapid as the driver mutations get fixation. For the parameter values listed in Table 1 and with N 0 = 2000, the population grows as driver mutations accumulate ( Fig. 2B and the red line in Fig. 3A) . However, at a higher µ, N (t)
shrinks as time progresses with N (t) → 0 (blue curve in Fig. 3A ).
Inclusion of MDs leads to qualitatively different results. There is complete absence of µ c in the model, which includes Ds, DPs, and MDs. Instead, we find that N (t) increases faster as µ increases leading to the occurrence of cancer more rapidly -a result that accords well with experimental observations 3 . In our model, the enhanced probability and rapid acquisition of cancer take place because the effect of DPs are compensated by the minidrivers and drivers. In accord with expectations, we find that cancer progression rate is very slow as µ deceases as shown by the orange lines in Fig. 3 . Therefore, cancer can be delayed if the mutation rate is decreased endogenously or exogenously. However, evolution would also be arrested or drastically slowed without mutation. From this perspective, cancer -a lethal disease, is a wicked by-product of evolution.
Effect of death rate on population growth. The growth in N (t) shown in Figs. 2-3 was obtained by assuming that the cell death rate increases linearly with N (Eq.
(2)). The populations increase as a new driver mutation starts to get fixation resulting in an increase in the cell fitness by s d . Simultaneously, D(N ) also increases as N becomes larger. In this model, N can only increase by a finite amount as each driver mutation gets fixation successfully. Other functions have also been considered for cell death rate in cancer research.
In the following, we discuss two different functions for cell death to illustrate the influence of the choice of D(N ) in tumor growth. A constant death rate is frequently utilized 33,35 , and we will consider this simplest function first. The evolution dynamics of cancers with Ds, MDs as well as DPs is illustrated in Fig. 4A . Here, D(N ) is a constant with the assumption that it equals the birth rate at t = 0. Initially, we observe homeostasis, especially when N 0 = 1000. This is followed by unbounded growth as the cells gain the first driver mutation irrespective of N 0 . It indicates that one driver mutation can lead to cancer, which in this instance occurs because the birth rate of cells is always much higher than the death rate after the first driver mutation gets fixation. The tumor grows to a macroscopic size in a very short time (Fig. 4A) .
A constant value for cell death rate is not very realistic because cells are subject to spatial, resources and other constraints as the population grows to macroscopic sizes. Stimulated by a previous study 33 , we propose another function for D(N ),
where K is a constant. If K = 1/N 0 , we recover Eq.
(2). The death rate is still an increasing function of the system size N , but it increases slowly as N reaches large values. This is physically reasonable because certain driver mutations can promote the survival of cells by decreasing the death rate as discussed above.
An interesting phenomenon emerges when Eq. (4) is utilized for D(N ). Initially, the growth dynamics (Fig. 4B ) is similar as in Figs. 2-3, with homeostasis interrupted by periods of rapid population growth. However, the tumor transits from a bounded to an unbounded growth after several drivers (four in this example) accumulate. Therefore, only a small number of drivers is required for the occurrence of cancers 1,2,28,33 . The precise number of drivers is controlled by variables such as K, which might explain the varied risks for the occurrence of different cancers. It takes much longer time to develop cancer if a larger number of drivers are required for cancer progression (Fig. 4) . Recently, it was found 36 that
African elephant which has a lower cancer mortality compared with human has at least 20 copies of TP53 (a tumor suppressor gene) while only one copy is present in humans. This observation provides a clue to resolve the Peto's paradox that large, long lived animals do not experience an increased risk of cancers 37 . Our simulations provide a qualitative explanation of Peto's paradox based on one choice of N -dependent D(N ).
Simulations explain the number of drivers and passengers in cancer data.
The number of drivers and passengers that accumulate in tumor cells under a variety of conditions is explored in Fig. S3-S6 . The identification of driver mutations is a central topic in cancer research 3,38 whereas the effects of passengers and mini-drivers have been ignored until recently 15,19,23 . The number of passengers increases as drivers accumulate in the same type of tumors 15, 19 . In order to assess if the relation between driver and passenger predicted here is consistent with experiments, we analyzed data from six clinical sets (Fig. 5 ) 15,19,39,40 .
In Fig. 5A, the values, which is consistent with previous studies 15 . It should be emphasized that passenger mutations were assumed to be neutral 15 , which is not the case in our study. Interestingly, there is a great deal of dispersion in the plot Fig. 5B . The fluctuations around the mean (red circles) is substantial. To the extent each curve in Fig. 5A (shown as green dots) represents the fate of a single cell population, the results show that there ought to be considerable heterogeneity in the plot of number of passengers versus drivers, as found in Fig. 5B .
Deleterious driver results in population extinction at high mutation rates.
So far, we have neglected the role of deleterious drivers (DDs) in the evolutionary growth model. Such mutations, which strongly reduce the fitness of tumor cells, could occur with some probability. Neglect of DDs is reasonable as long as the mutation rate (µ) is small.
However, µ can be enhanced by specific (epi)genetic mutations, chromosomal instability (CIN), or carcinogens 3 . We show that DDs can play an important role as µ reaches high values.
We generalized the model to investigate the effect of DDs. We take the fitness disadvantage s dd = s d = 0.1 for DDs. The number L dd of DDs loci, which are associated with essential genes, is taken to be 10 4 (see SI for an explanation of this choice). The evolution of N (t) at different µ values, plotted in the upper panel of Fig. 6 , shows that the DDs do not influence the evolution of N (t) as long as µ 10 −4 . In this limit, the growth of N (t) is similar to that reported in Fig. 2C . Occurrence of cancer is more rapid as µ increases (see also Fig. 3B ). The average number of DDs in a single tumor cell is negligible if µ 10 −4 (lower panel in Fig. 6 ). Therefore, DDs can be neglected as long as µ is relatively small 19 .
However, there is a dramatic change in the growth dynamics with tumor driven to extinction if µ > 10 −5 as shown by the lines in orange and red in Fig. 6 . This finding is not observed in a model including only Ds, MDs, and DPs (Fig. 2C) . At such high mutation rates, the number of accumulated DDs in tumor cells increases rapidly, as illustrated by the open symbols in orange and red in Fig. 6 . This results in a strong reduction of the fitness of tumor cells leading to the extinction of the population. The critical mutation rate constant µ c (> 10 −5 ) decreases as L dd increases (a high mutation rate for DDs can still be maintained).
The surprising finding that the extinction of N (t) at high µ due to the presence of
DDs explains the counterintuitive correlation between high chromosomal instability (CIN)
and improved prognosis for clinical outcome in a number of cancers 41,42 . Based on a score accounting for DNA based chromosomal complexity and CIN, which correlates with gene expression in ∼ 2,000 breast tumors, it was found that the tumors with high CIN had greater prognosis compared with intermediate CIN. Our result, showing that only at high µ the presence of DDs is poorly tolerated by cancer cells, is consistent with the observed paradoxical relationships between high CIN and improved clinical outcome. These CIN scores can be calculated using microarray expression data available publicly, and hence it stands to reason that the genes for DDs can be identified. If so, enhancing their mutation rate might be a viable therapy for some forms of cancer.
Interestingly, it was also previously shown that the probability of cancer decreases if µ exceeds ∼ 4 · 10 −9 using a model with only drivers and deleterious passengers 19 . This observation also explains the paradox between improved cancer prognosis and high CIN. The decrease in cancer incidence in our model occurs at mutation rates > 10 −5 provided DDs are taken into account. The difference of (3-4) orders of magnitude between our predictions and the one estimated elsewhere 19 for the critical mutation rate will require experiments. The spontaneous random mutation rate at the single nucleotide level in normal cells 43 is around 10 −9 to 10 −10 while the rate is nearly (2-4) orders of magnitude higher in tumor cells 44, 45 which is in accord with the values obtained in this work. We conjecture (further experiments are needed) that µ needs to exceed 10 −5 for a decrease in the probability of cancer. It should be emphasized that it is likely that high mutation rates trigger T-cell response that results in control of cancer growth rather than decreasing the fitness of cancer cells. Such a mechanism could also explain the successes of immunotherapy 46 in the treatment of high mutation rate cancers such as melanoma. These two mechanisms are not mutually exclusive and could operate in concert.
DISCUSSION
We investigated the interplay between rare driver mutations that confer distinct fitness advantage to cancer cells, and the numerous but weak mini-drivers and deleterious passengers in the evolution of cancer. These conflicting effects, such as the mini tug-of-war between the MDs and DPs, result in rich dynamics in tumor growth. Simulations based on the new evolutionary model show that both DPs and MDs profoundly impact the growth dynamics of tumors. By including MDs, we find that the dynamics of population growth exhibit intermittency with periods of homeostasis (plateaus in N (t)) followed by bursts in the growth.
If DPs are totally ignored and dynamics only with Ds and MDs are considered the population grows continuously with varying growth rates (see Fig. S8 in the SI (2)). Cells accumulate driver, mini-driver and deleterious passenger mutations with rates µL d , µL md , and µL dp respectively, after each cell division. A single driver mutation increases the cell viability by s d while a mini-driver (deleterious passenger) confers fitness advantage (disadvantage) by s md (s dp ). L dd , number of deleterious driver loci 10 4 s d , fitness increase for one driver mutation 0.1 s p , fitness decrease for one passenger mutation 0.001
